Ldl cholesterol 132
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Understanding LDL Cholesterol and Its Impact on Health
LDL Cholesterol and Atherosclerotic Cardiovascular Disease (ASCVD)
Low-density lipoprotein cholesterol (LDL-C) is a significant risk factor for atherosclerotic cardiovascular disease (ASCVD), which includes conditions such as myocardial infarction and ischemic stroke. Research indicates that elevated LDL-C levels are strongly associated with the occurrence of ASCVD events, particularly in individuals with existing coronary atherosclerosis, as evidenced by coronary artery calcification (CAC). In a study involving 23,132 symptomatic patients, those with CAC showed a higher risk of ASCVD events with increasing LDL-C levels, while no significant association was found in patients without CAC. This suggests that the presence of coronary atherosclerosis is a critical factor in the risk assessment of ASCVD related to LDL-C levels.
Variability in LDL Cholesterol Measurement
The measurement of LDL cholesterol is crucial for evaluating the risk of coronary heart disease and the effectiveness of lipid-modifying therapies. However, different assays for measuring LDL-C can yield varying results due to methodological differences. This heterogeneity in LDL-C values across different assays underscores the need for awareness and standardization in clinical practice to ensure accurate risk assessment and treatment efficacy.
Cholesterol-Lowering Mechanisms of Probiotics
Recent studies have explored the potential of probiotics in managing hypercholesterolemia. Specifically, Enterococcus faecium strain 132 and Lactobacillus paracasei strain 201 have shown promising results in reducing LDL-C levels in hypercholesterolemic rats. These strains not only decreased serum total cholesterol and LDL-C but also improved the overall lipid profile by reducing triglycerides and liver cholesterol levels. The mechanism involves the regulation of genes related to cholesterol metabolism and the alteration of gut microbiota, which collectively contribute to the reduction of fat accumulation and inflammation. These findings suggest that such probiotic strains could be developed into functional foods aimed at managing hypercholesterolemia.
Conclusion
LDL cholesterol plays a pivotal role in the development of atherosclerotic cardiovascular diseases, particularly in individuals with coronary atherosclerosis. Accurate measurement and management of LDL-C are essential for effective risk assessment and treatment. Additionally, probiotics like Enterococcus faecium strain 132 and Lactobacillus paracasei strain 201 offer a novel approach to lowering LDL-C and improving lipid profiles, potentially serving as functional foods for hypercholesterolemia management.
Sources and full results
Most relevant research papers on this topic